1. European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations. (3rd September 2022) Authors: Wollenberg, A.; Kinberger, M.; Arents, B.; Aszodi, N.; Avila Valle, G.; Barbarot, S.; Bieber, T.; Brough, H.A.; Calzavara Pinton, P.; Christen‐Zäch, S.; Deleuran, M.; Dittmann, M.; Dressler, C.; Fink‐Wagner, A.H.; Fosse, N.; Gáspár, K.; Gerbens, L.; Gieler, U.; Girolomoni, G.; Gregoriou, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: 1904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy. (18th August 2022) Authors: Wollenberg, A.; Kinberger, M.; Arents, B.; Aszodi, N.; Avila Valle, G.; Barbarot, S.; Bieber, T.; Brough, H.A.; Calzavara Pinton, P.; Christen‐Zäch, S.; Deleuran, M.; Dittmann, M.; Dressler, C.; Fink‐Wagner, A.H.; Fosse, N.; Gáspár, K.; Gerbens, L.; Gieler, U.; Girolomoni, G.; Gregoriou, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). (19th April 2018) Authors: Chalmers, J.R.; Thomas, K.S.; Apfelbacher, C.; Williams, H.C.; Prinsen, C.A.; Spuls, P.I.; Simpson, E.; Gerbens, L.A.A.; Boers, M.; Barbarot, S.; Stalder, J.F.; Abuabara, K.; Aoki, V.; Ardeleanu, M.; Armstrong, J.; Bang, B.; Berents, T.L.; Burton, T.; Butler, L.; Chubachi, T. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). (1st May 2018) Authors: Chalmers, J.R.; Thomas, K.S.; Apfelbacher, C.; Williams, H.C.; Prinsen, C.A.; Spuls, P.I.; Simpson, E.; Gerbens, L.A.A.; Boers, M.; Barbarot, S.; Stalder, J.F.; Abuabara, K.; Aoki, V.; Ardeleanu, M.; Armstrong, J.; Bang, B.; Berents, T.L.; Burton, T.; Butler, L.; Chubachi, T. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TSLP, IL‐31, IL‐33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. (6th May 2016) Authors: Nygaard, U.; Hvid, M.; Johansen, C.; Buchner, M.; Fölster‐Holst, R.; Deleuran, M.; Vestergaard, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 11(2016:Nov.) Page Start: 1930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗